NCT07159620 Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients Status RECRUITING Phase PHASE2
NCT07150104 Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT07150091 Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethasone in Participants With RRMM Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT07139522 Dexamethasone Versus Magnesium Sulphate as an Adjuvant to Bupivacaine in Ultrasound Guided Erector Spinae Plane Block for Postoperative Analgesia in Elective Caesarean Section Under Spinal Anesthesia Status RECRUITING Phase NA
NCT07138209 A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma Status RECRUITING Phase PHASE3
NCT07101445 Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial Status RECRUITING Phase PHASE4
NCT07096778 Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Status RECRUITING Phase PHASE2
NCT07095452 A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant Status RECRUITING Phase PHASE2/PHASE3
NCT07088432 Intravenous Dexamethasone for Prolonging Sensory Block in Spinal Anesthesia Status COMPLETED Phase NA
NCT07088146 Dexamethasone in Prolonging the Duration of Spinal Anesthesia Among Pregnant Patients Status RECRUITING Phase PHASE4
NCT07086118 Dexamethasone Versus Metoclopramide for Prophylaxis of Nausea and Vomiting After Cataract Surgery Status RECRUITING Phase NA
NCT07085728 Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT07084285 Cervical Facet Injection of Corticosteroids for the Management of Cervicobrachialgia Status NOT_YET_RECRUITING Phase PHASE3
NCT07082270 Selvigaltin With Standard of Care Treatment for the Treatment of Relapsed/Refractory Multiple Myeloma Status WITHDRAWN Phase PHASE1
NCT07078786 Effect of Pre-delivery Dexamethasone in Comparison With Betamethasone on Fetal Heart Trace Status RECRUITING Phase PHASE4
NCT07072585 Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) Status NOT_YET_RECRUITING Phase PHASE2/PHASE3
NCT07072234 Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell Carcinoma Status RECRUITING Phase PHASE1
NCT07068230 Ondansetron and Dexamethasone for Prevention of PDPH, Nausea, and Vomiting Status COMPLETED Phase PHASE4